HY-107471-25mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-5mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-107471-50mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
HY-118798-10mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-118798-25mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-118798-5mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
HY-N0674A-1mg
|
MedChemexpress LLC
|
Dehydrocorydaline (chloride) [CAS 10605-03-5]
|
|
Cancer-Kinase/protease
|
|
HY-N0674A-10mg
|
MedChemexpress LLC
|
Dehydrocorydaline (chloride) [CAS 10605-03-5]
|
|
Cancer-Kinase/protease
|
|
HY-N0674A-5mg
|
MedChemexpress LLC
|
Dehydrocorydaline (chloride) [CAS 10605-03-5]
|
|
Cancer-Kinase/protease
|
|
HY-N0674A-1mL
|
MedChemexpress LLC
|
Dehydrocorydaline (chloride) [CAS 10605-03-5] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-N0674B-10mg
|
MedChemexpress LLC
|
Dehydrocorydaline (hydroxyl)
|
|
COVID-19-anti-virus
|
|
HY-N0674B-5mg
|
MedChemexpress LLC
|
Dehydrocorydaline (hydroxyl)
|
|
COVID-19-anti-virus
|
|
HY-N4238-10mg
|
MedChemexpress LLC
|
Dehydrocorydaline (nitrate) [CAS 13005-09-9]
|
|
COVID-19-immunoregulation
|
|
HY-N4238-5mg
|
MedChemexpress LLC
|
Dehydrocorydaline (nitrate) [CAS 13005-09-9]
|
|
COVID-19-immunoregulation
|
|
HY-N0674-1mg
|
MedChemexpress LLC
|
Dehydrocorydaline [CAS 30045-16-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0674-10mg
|
MedChemexpress LLC
|
Dehydrocorydaline [CAS 30045-16-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0674-5mg
|
MedChemexpress LLC
|
Dehydrocorydaline [CAS 30045-16-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0674-1mL
|
MedChemexpress LLC
|
Dehydrocorydaline [CAS 30045-16-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-142283AS-1mg
|
MedChemexpress LLC
|
Dosimertinib (mesylate)
|
|
Cancer-Kinase/protease
|
|
HY-142283AS-10mg
|
MedChemexpress LLC
|
Dosimertinib (mesylate)
|
|
Cancer-Kinase/protease
|
|
HY-142283AS-5mg
|
MedChemexpress LLC
|
Dosimertinib (mesylate)
|
|
Cancer-Kinase/protease
|
|
HY-149824-10mg
|
MedChemexpress LLC
|
EGFR T790M/L858R-IN-2
|
|
|
|
HY-149824-100mg
|
MedChemexpress LLC
|
EGFR T790M/L858R-IN-2
|
|
|
|
HY-149824-25mg
|
MedChemexpress LLC
|
EGFR T790M/L858R-IN-2
|
|
|
|
HY-149824-5mg
|
MedChemexpress LLC
|
EGFR T790M/L858R-IN-2
|
|
|
|